Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q24246227)
Watch
English
Cilostazol for peripheral arterial disease
scientific article (published 2007-01-24)
In more languages
edit
Statements
instance of
scholarly article
0 references
meta-analysis
0 references
review article
1 reference
stated in
Europe PubMed Central
title
Cilostazol for peripheral arterial disease
(English)
0 references
author name string
P Robless
series ordinal
1
author given names
P
author last names
Robless
1 reference
stated in
PubMed
PubMed ID
17253494
retrieved
26 November 2023
DP Mikhailidis
series ordinal
2
author given names
D P
author last names
Mikhailidis
1 reference
stated in
PubMed
PubMed ID
17253494
retrieved
26 November 2023
GP Stansby
series ordinal
3
author given names
G P
author last names
Stansby
1 reference
stated in
PubMed
PubMed ID
17253494
retrieved
26 November 2023
publication date
24 January 2007
0 references
published in
Cochrane Database of Systematic Reviews
0 references
cites work
Angioplasty (versus non surgical management) for intermittent claudication
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB2
retrieved
21 January 2018
A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Exercise for intermittent claudication.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Life-style modification in peripheral arterial disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparative effects of cilostazol and other therapies for intermittent claudication
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Analysis of the cilostazol safety database
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A comparison of cilostazol and pentoxifylline for treating intermittent claudication
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiplatelet therapy in peripheral arterial disease. Consensus statement
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of cilostazol in patients with intermittent claudication: a randomized, double-blind, placebo-controlled study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The role of cilostazol in the treatment of intermittent claudication
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oral naftidrofuryl. A review of its pharmacology and therapeutic use in the management of peripheral occlusive arterial disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cilostazol: a review of its use in intermittent claudication
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1002/14651858.CD003748.PUB2
0 references
Fatcat ID
release_t5jegzvz5ne73kurg6w7b2apmi
0 references
PubMed ID
17253494
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
